Clinical Trial Update: A Safety and Tolerability Study of GB301 [Phase 1, Phase 2]

View source ↗

Summary

A safety and tolerability study of GB301 in Alzheimer disease across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GB301

Snippet

Sponsor: VTBIO Co. LTD | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: UNKNOWN